These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3931471)

  • 1. Hyperalimentation as cause of markedly worsened metabolic control in a patient with autoantibodies to the insulin receptor.
    Vesely DL; Coleman MJ; Kohler PO; Jordan RM; Stanley S
    Am J Med; 1985 Oct; 79(4):504-8. PubMed ID: 3931471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin receptor antibodies and insulin resistance.
    Magsino CH; Spencer J
    South Med J; 1999 Jul; 92(7):717-9. PubMed ID: 10414483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of type B insulin resistance: a novel approach to reduce insulin receptor autoantibodies.
    Malek R; Chong AY; Lupsa BC; Lungu AO; Cochran EK; Soos MA; Semple RK; Balow JE; Gorden P
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3641-7. PubMed ID: 20484479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type B Insulin Resistance in Peru.
    Zelada H; Gamarra D; Arbañil H; Manrique H
    Am J Med Sci; 2017 Mar; 353(3):258-262. PubMed ID: 28262212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of acanthosis nigricans correlates with disappearance of anti-insulin receptor autoantibodies and achievement of euglycemia in type B insulin resistance syndrome.
    Fareau GG; Maldonado M; Oral E; Balasubramanyam A
    Metabolism; 2007 May; 56(5):670-5. PubMed ID: 17445543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic lupus erythematosus with acanthosis nigricans, hyperpigmentation, and insulin receptor antibody.
    Baird JS; Johnson JL; Elliott-Mills D; Opas LM
    Lupus; 1997; 6(3):275-8. PubMed ID: 9104736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-resistant diabetes with insulin receptor autoantibodies in a male patient without acanghosis nigricans.
    Baldwin D; Winston E; Hoshizaki RJ; Garland JT; Baldwin D; Holcomb HH; Flier JS; Rubenstein A
    Diabetes Care; 1979; 2(3):275-7. PubMed ID: 510120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against the insulin receptor in paraneoplastic acanthosis nigricans.
    Matsuoka LY; Goldman J; Wortsman J; Kleinsmith D; Kupchella CE
    Am J Med; 1987 Jun; 82(6):1253-6. PubMed ID: 3605142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and acanthosis nigricans. Report of a case with antibodies to insulin receptors.
    Pulini M; Raff SB; Chase R; Gordon EE
    Ann Intern Med; 1976 Dec; 85(6):749-51. PubMed ID: 1087135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to the insulin receptor impair clearance of plasma endogenous insulin.
    Kiyokawa H; Kono N; Hamaguchi T; Kawachi M; Tajima K; Yamada Y; Hara N; Mineo I; Kuwajima M; Tarui S
    Diabetes Res Clin Pract; 1989; 7 Suppl 1():S41-4. PubMed ID: 2680366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of type B insulin resistance with rituximab.
    Manikas ED; Isaac I; Semple RK; Malek R; Führer D; Moeller LC
    J Clin Endocrinol Metab; 2015 May; 100(5):1719-22. PubMed ID: 25675382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.
    Kahn CR; Baird K; Filier JS; Jarrett DB
    J Clin Invest; 1977 Nov; 60(5):1094-106. PubMed ID: 908753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to the insulin receptor: clinical significance and experimental applications.
    Harrison LC; Kahn CR
    Prog Clin Immunol; 1980; 4():107-25. PubMed ID: 6992216
    [No Abstract]   [Full Text] [Related]  

  • 14. IMAGES IN CLINICAL MEDICINE. Acanthosis Nigricans and Insulin Resistance.
    Lauria MW; Saad MJ
    N Engl J Med; 2016 Jun; 374(24):e31. PubMed ID: 27305209
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anti-insulin receptor antibody--its measurement and significance].
    Kobayashi M; Shigeta Y
    Nihon Rinsho; 1990 Dec; 48 Suppl():308-14. PubMed ID: 1707991
    [No Abstract]   [Full Text] [Related]  

  • 16. Unusual forms of insulin resistance.
    Taylor SI; Accili D; Cama A; Imano E; Kadowaki H; Kadowaki T
    Annu Rev Med; 1991; 42():373-9. PubMed ID: 2035982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful immunosuppressive therapy in a patient with autoantibodies to insulin receptors and immune complex glomerulonephritis.
    Sims RE; Rushford FE; Huston DP; Cunningham GR
    South Med J; 1987 Jul; 80(7):903-6. PubMed ID: 3603112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Insulin resistant diabetes showing anti-insulin receptor autoantibody with systemic scleroderma, acanthosis nigricans and total lipodystrophy (author's transl)].
    Sugawara H; Toyota T; Okuguchi F; Umezu M; Kai Y; Abe R; Maruhama Y; Goto Y; Hanew K; Utsumi N
    Nihon Naika Gakkai Zasshi; 1980 Mar; 69(3):361-9. PubMed ID: 7381285
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical course of the syndrome of autoantibodies to the insulin receptor (type B insulin resistance): a 28-year perspective.
    Arioglu E; Andewelt A; Diabo C; Bell M; Taylor SI; Gorden P
    Medicine (Baltimore); 2002 Mar; 81(2):87-100. PubMed ID: 11889410
    [No Abstract]   [Full Text] [Related]  

  • 20. Generalized acanthosis nigricans related to type B insulin resistance syndrome: a case report.
    Jeong KH; Oh SJ; Chon S; Lee MH
    Cutis; 2010 Dec; 86(6):299-302. PubMed ID: 21284281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.